|
Volumn 35, Issue 12, 2013, Pages 936-940
|
[Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
ANTINEOPLASTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CANDESARTAN;
CARBAZOLE DERIVATIVE;
CARVEDILOL;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
FLUOROURACIL;
PROPANOLAMINE DERIVATIVE;
TETRAZOLE DERIVATIVE;
TROPONIN;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
ELECTROCARDIOGRAPHY;
FEMALE;
HEART ARRHYTHMIA;
HEART STROKE VOLUME;
HUMAN;
MASTECTOMY;
METABOLISM;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
AGED;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARRHYTHMIAS, CARDIAC;
BENZIMIDAZOLES;
BREAST NEOPLASMS;
CARBAZOLES;
CHEMOTHERAPY, ADJUVANT;
CYCLOPHOSPHAMIDE;
ELECTROCARDIOGRAPHY;
EPIRUBICIN;
FEMALE;
FLUOROURACIL;
HUMANS;
MASTECTOMY, RADICAL;
MIDDLE AGED;
PROPANOLAMINES;
STROKE VOLUME;
TETRAZOLES;
TROPONIN;
|
EID: 84906054239
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (26)
|
References (0)
|